A.D.A.M. shareholders approve Agreement and Plan of Merger with Ebix

NewsGuard 100/100 Score

A.D.A.M., Inc. (Nasdaq: ADAM), a leading provider of innovative online technology solutions for the health, benefits and education markets, today announced that its shareholders have approved the Agreement and Plan of Merger, dated as of August 29, 2010, by and among A.D.A.M., Ebix, Inc. ("Ebix") and Eden Acquisition Sub, Inc., a direct wholly owned subsidiary of Ebix.

More than 61 percent of the outstanding shares of A.D.A.M. common stock were voted in favor of the merger during the Special Meeting of Shareholders held on February 4, 2011. This vote exceeded the required threshold, which was approval by a majority vote of the outstanding shares. Of the shares voted, over 99 percent voted in favor of the merger.

Under the terms of the merger agreement, at the closing of the merger, each share of common stock of A.D.A.M. will be converted into the right to receive 0.3122 shares of common stock of Ebix. A.D.A.M. has adequate cash on hand to meet the minimum requirements of the merger agreement, so no purchase price adjustment to the exchange ratio is necessary. Pursuant to the terms of the merger agreement, the merger shall occur within three business days after satisfaction of all the conditions to the merger. A.D.A.M. believes it has fully performed its obligations and satisfied its closing conditions under the merger agreement.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Get heart smart: Transforming cardiovascular health through diet and education